| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $37.4M | — | +28.7% |
| SG&A Expense | $6.9M | — | -14.5% |
| Operating Income | -$44.3M | — | -19.3% |
| Interest Expense | $636K | — | +116.3% |
| Income Tax | $0 | — | — |
| Net Income | -$43.5M | — | -21.1% |
| EPS (Basic) | -$0.39 | — | +45.1% |
| EPS (Diluted) | -$0.39 | — | +45.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $116.6M | +40.6% | -11.5% |
| Short-term Investments | $0 | -100.0% | — |
| Current Assets | $122.3M | -11.9% | -9.1% |
| Total Assets | $148.1M | -10.3% | -10.3% |
| Current Liabilities | $41.5M | -17.2% | +22.1% |
| Total Liabilities | $44.8M | -15.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.6M | — | -38.2% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $51.0M | — | +6591.7% |
| Financing Cash Flow | $25.3M | — | +4677.4% |
| Free Cash Flow | -$42.6M | — | -34.7% |
| +2.9% |
| Stockholders' Equity | $103.3M | -7.8% | -15.0% |